Aim: To synthesize and compare outcomes from controlled trials of interventions to improve heart failure self-care among adults.
| INTRODUCTION
Heart failure (HF) afflicts over 5.7 million persons in the United States and at least 23 million people worldwide (Heidenreich et al., 2013; Mozaffarian et al., 2015) . HF risks are well documented and include high morbidity and mortality, frequent hospitalization, high healthcare costs, impaired functional status and poor quality of life (Gheorghiade, Vaduganathan, Fonarow, & Bonow, 2013; Jaarsma, Johansson, Agren, & Stromberg, 2010; Kochanek, Murphy, Xu, & Arias, 2014; Mozaffarian et al., 2015; Riegel, Moser, et al., 2009; Roger et al., 2012; Zambroski, Moser, Bhat, & Ziegler, 2005) .
Although HF mortality rates have improved somewhat over the past 20 years, the improvement is small and overall deaths due to HF continue to rise (Benjamin et al., 2017) . Despite many advances in HF treatment, key clinical and patient-reported outcomes such as hospitalization rates and health-related quality of life have not improved since 2000 (Mozaffarian et al., 2015) .
| Background
HF self-care is a concept that encompasses a set of health behaviours associated with improved patient outcomes (Riegel et al., 2017) . HF self-care behaviours include-but are not limited tomedication taking, exercise, diet, weight measurement, symptom recognition and response and fluid management (Riegel, Moser, et al., 2009; Yancy et al., 2013) . HF treatment guidelines emphasize the need for patients to implement HF self-care strategies to achieve the best possible outcomes (Lindenfeld et al., 2010; Riegel, Moser, et al., 2009; Yancy et al., 2013) . However, many patients do not successfully or reliably implement these behaviours, leading to poorer outcomes than could be attained if they were to engage in self-care.
Numerous studies have tested interventions to improve HF selfcare behaviours and associated outcomes. A lack of adequate research synthesis has prevented conclusions about the comparative effectiveness of HF self-care interventions, leading to a lack of clarity in practice guideline recommendations for HF self-care (Lindenfeld et al., 2010; Yancy et al., 2013) . Comparative effectiveness analyses are necessary to facilitate improved patient, provider and health system outcomes for HF.
| THE REVIEW

| Aims
The purpose of this systematic review and meta-analysis is to integrate scientific knowledge about interventions to enhance self-care for adult HF patients, including an understanding of which factors influence the success of interventions on self-care behavioural outcomes and on important clinical outcomes. We seek to answer the following research questions: (a) What are the overall effects of HF self-care interventions on self-care behavioural outcomes (medication adherence, exercise/physical activity, adherence to a low-sodium diet, daily weight measurement, symptom recognition, fluid management, annual influenza vaccination and keeping appointments)? (b) What are the overall effects of HF self-care interventions on clinical outcomes (mortality, readmissions, disease severity, healthcare use and quality of life)? (c) How do intervention effects on self-care behaviour and health outcomes vary based on study design characteristics and risks of bias? (d) Are HF self-care interventions more effective for certain patient populations, based on factors such as disease severity, gender, ethnicity/race, age or prescribed drugs? (e) How do effects of interventions on self-care behaviour and health outcomes vary depending on intervention characteristics (e.g., intervention content, combination of intervention components, intervention dose and type of interventionists)?
| Methodology
This project will follow standard systematic review methods and use a random-effects meta-analytic approach to synthesize the review findings. Exploratory moderator analyses will be used to explain heterogeneity and generate hypotheses for further research. as taking an additional diuretic in response to increased oedema (Riegel, Moser, et al., 2009; Riegel et al., 2017; Yancy et al., 2013 ).
Studies we review may offer additional self-care behaviours, which we will add to the codebook and include in the data set.
Studies of cognitively impaired and/or institutionalized individuals will be excluded due to many of their HF self-care behaviours being managed or controlled by others. Only two-group (controlled) trials will be included in the meta-analysis. We will only include studies published in English; however, we will also include non-English studies if they have an English-language version of the abstract containing sufficient data for effect size (ES) calculation. Table 1 . We will then conduct ancestry searches using the reference lists of eligible studies and review articles and search the tables of contents for the past 10 years in journals that published eligible studies. We will use Scopus to search for additional publications by the first and senior authors of eligible studies. Including these additional search strategies yields more eligible studies than relying solely on computerized database searching (Morrisey & DeBourgh, 2001 ).
| Search strategy for identification of studies
We will also search for unpublished studies, as the primary difference between published and unpublished studies is not their methodological quality, but rather the significance of the results.
These searches will include searches of research registries (e.g., clinicaltrials.gov) and conference abstracts to identify unpublished stud- . All citations from searches will be managed using an EndNote database to facilitate screening of titles and abstracts.
| Trial eligibility and methodological quality assessment
Initial search results will be screened by two members of the research team. In this screening, titles and abstracts will be read to evaluate whether the study includes an intervention to improve an aspect of HF self-care. Any possibly eligible citations will be marked for full-text retrieval. The full text of possibly eligible studies will then be reviewed and for non-eligible studies, the reasons for ineligibility will be noted in the study tracking database. A study will not be excluded until it is clear that it does not fulfil inclusion criteria.
Likewise, any study that appears to lack sufficient data to calculate an effect size will not be excluded until completing all searches for other publications on the same study and contacting the study authors to request additional data.
Study quality will be addressed in two ways. First, two members of the research team will independently evaluate eligible studies using the Cochrane Collaboration's Risk for Bias tool, which permits grading each domain of potential bias as "low risk," "high risk" or "unclear risk" . Second, we will consider methodological quality as an empirical question, coding data about aspects of study quality and potential risks for bias, and then analysing that data in moderator analyses to see whether potential risks for bias are significantly related to study effect size. 
| Data collection and validation
Data will be independently extracted by two coders, who will then make data comparisons until 100% agreement is reached on every coding item. Electronic coding forms and databases will be used to reduce errors and facilitate data comparison to check for accuracy.
The data extraction codebook is based on a structure used in prior meta-analyses and has been pilot tested. Intervention components will be coded using the Behavior Change Technique Taxonomy (Michie et al., 2013) to facilitate interpretation across other studies and reviews.
| Outcome measures
We will conduct a series of meta-analyses on multiple behavioural outcomes: medication adherence, exercise/physical activity, adherence to a low-sodium diet, daily weight measurement, symptom recognition, fluid management, annual influenza vaccination and adherence to clinic appointments. Some of these behavioural outcomes will be more frequently reported than others across studies and some may only be captured in more global HF self-care measures, such as the Self-Care of Heart Failure Index (Riegel, Lee, Dickson, & Carlson, 2009 ).
We will also extract data on the following clinical outcomes: mortality, readmissions, disease severity, healthcare use and quality of life. Similar to the behavioural outcomes, not all clinical outcomes will necessarily be reported across all studies, so the final list of outcomes to be analysed will be determined by the extent of the reported and usable data.
| Data analysis
Descriptive statistics will be calculated using SPSS to report characteristics of the studies, samples and interventions. We will then use Comprehensive Meta-Analysis software (Biostat, Inc., Englewood, NJ, USA) to calculate an ES for each codable outcome from each study, using standardized mean difference for continuous variables and relative risk for dichotomous events. When results from the same study are reported across multiple papers, we will group them as companion papers and report the results as a single study. When studies report multiple intervention groups, we will code the intervention groups as separate comparisons. If needed and appropriate, data from multiple intervention groups in the same study may be combined into a single pair-wise comparison for analysis (Higgins & Green, 2011) . Mean ES across studies will then be calculated, including heterogeneity statistics (Q and I 2 ), using a random-effects model. The random-effects model is appropriate for these analyses due to the expected variation in interventions and samples found across HF self-care intervention studies. Separate meta-analyses will be conducted for each type of outcome. Potential outliers will be identified graphically using forest plots and statistically by checking for large standardized residuals. We will then conduct meta-regression and sub-group analyses to investigate the impact of differences in intervention types, patient demographics and study designs on ES.
| Analysing and mitigating risks for bias
Whether publication bias is present will be assessed visually by examining funnel plots and statistically using Egger's test (Egger, Davey Smith, Schneider, & Minder, 1997; Higgins & Green, 2011) .
Each ES will be weighted by the reciprocal of its sampling variance to give larger sample sizes more influence in the meta-analyses.
Studies will be carefully evaluated to avoid including the same study more than once in any meta-analysis. For instance, when the same author is included on multiple publications, the study characteristics (methods, sample sizes) will be compared to determine whether the publications are reporting separate studies or are companion papers reporting different analyses (i.e., time points, subgroups) of the same sample of patients.
| Ethical considerations
This research is being conducted using meta-analysis methods with existing trial data. The analyses will not include any identifiable patient data. Ethical committee approval was not required for this research.
| Validity, reliability and rigour
The project will be implemented using best practices in systematic review and meta-analysis methods (Borenstein, Hedges, Higgins, & Rothstein, 2009; Cooper, 2010) . Results will be reported according to the PRISMA guidelines for reporting the results of systematic reviews and meta-analyses (Moher, Liberati, Tetzlaff, & Altman, 2009 ).
| DISCUSSION
This comparative effectiveness study will allow us to identify the most promising targets for intervention development to improve HF self-care and related outcomes. Not only will the planned moderator analyses identify the most effective intervention components, but we will also be able to explore how intervention efficacy may vary for different patient populations. While this project will use aggregated retrospective data, large meta-analyses can compare the effectiveness of different approaches at far less cost than a prospective trial designed to compare multiple interventions.
| Limitations
Any systematic review and meta-analysis is limited by the number of available studies on the topic, the level of detail about interventions in the study reports and the types of data reported for calculating effect sizes. We will make every effort to include all eligible studies and will contact the authors of primary studies that do not report sufficient data for effect size calculation.
| CONCLUSION
This meta-analysis will compare the efficacy of HF self-care interventions, providing data on which intervention components are associated with the greatest improvement in outcomes and which patient populations are more likely to respond to certain types of interventions. Results from this project will contribute to the development of targeted interventions for specific patient groups. Furthermore, the findings may shed light on the relative usefulness of different intervention components for assisting patients with self-care behaviour change and achieving desired clinical outcomes.
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